Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: correction: Date assigned 2/5/08. so this is a new projection from Dutton?

d2006s,

The Dutton report was updated late on 2/29/08.

The initial or 1st Dutton report target was $1.12 in 2006. I'm sure you figured all this out by now but I didn't want to be rude and so I'm responding out of courtesy.

Accentuate the Positive!

Share
New Message
Please login to post a reply